We are live on ! Find out more
CM

Crestline Management Portfolio holdings

AUM $46.3M
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
+25.68%
1 Year Est. Return
+48.82%
3 Year Est. Return
+52.52%
5 Year Est. Return
+37.91%
10 Year Est. Return
+316.44%
AUM
$746M
AUM Growth
+$200M
Cap. Flow
+$60.8M
Cap. Flow %
8.15%
Top 10 Hldgs %
76.52%
Holding
190
New
78
Increased
30
Reduced
20
Closed
61

Top Buys

Rank Stock Value
1
MON
Monsanto Co
MON
+$6.18M
2
VRSK icon
Verisk Analytics
VRSK
+$5.61M
3
APD icon
Air Products & Chemicals
APD
+$4.62M
4
DNB
Dun & Bradstreet
DNB
+$4.57M
5
HON icon
Honeywell
HON
+$4.05M

Top Sells

Rank Stock Value
1
FNB icon
FNB Corp
FNB
+$5.19M
2
DOV icon
Dover
DOV
+$4.9M
3
ASB icon
Associated Banc-Corp
ASB
+$3.9M
4
KEY icon
KeyCorp
KEY
+$3.73M
5
PACW
PacWest Bancorp
PACW
+$2.93M

Sector Composition

Rank Sector Weight
1 Financials 12.55%
2 Healthcare 6.08%
3 Industrials 5.43%
4 Materials 3.1%
5 Technology 1.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
V icon
26
Visa
V
$684B
$2.65M 0.36%
+28,254
New +$2.62M
BIIB icon
27
Biogen
BIIB
$30B
$2.59M 0.35%
+9,543
New +$2.52M
AGU
28
DELISTED
Agrium
AGU
$2.58M 0.35%
28,500
-21,500
-43% -$1.99M
AIZ icon
29
Assurant
AIZ
$13.8B
$2.53M 0.34%
+24,376
New +$2.43M
UBSI icon
30
United Bankshares
UBSI
$6.63B
$2.43M 0.33%
+62,000
New +$2.46M
MET icon
31
MetLife
MET
$61.9B
$2.39M 0.32%
+48,869
New +$2.27M
FICO icon
32
Fair Isaac
FICO
$24.3B
$2.31M 0.31%
+16,545
New +$2.21M
AMTD
33
DELISTED
TD Ameritrade Holding Corp
AMTD
$2.3M 0.31%
+53,407
New +$2.07M
FITB
34
Fifth Third Bancorp
FITB
$51.2B
$2.21M 0.3%
+85,000
New +$2.1M
CFG icon
35
Citizens Financial Group
CFG
$30.3B
$2.14M 0.29%
+60,000
New +$2.13M
USB icon
36
US Bancorp
USB
$98.2B
$2.08M 0.28%
40,000
-30,000
-43% -$1.55M
SRPT icon
37
Sarepta Therapeutics
SRPT
$1.57B
$2.07M 0.28%
61,410
+28,810
+88% +$938K
JBLU icon
38
JetBlue
JBLU
$2.28B
$2.06M 0.28%
90,000
-50,000
-36% -$1.1M
NBIX icon
39
Neurocrine Biosciences
NBIX
$16.8B
$2.05M 0.28%
+44,658
New +$2.17M
BMRN icon
40
BioMarin Pharmaceuticals
BMRN
$11.6B
$2.05M 0.27%
22,592
-2,207
-9% -$201K
CATY icon
41
Cathay General Bancorp
CATY
$4.22B
$2.05M 0.27%
54,000
+34,000
+170% +$1.28M
ATH
42
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
$2.02M 0.27%
+40,698
New +$2.09M
BOH icon
43
Bank of Hawaii
BOH
$3.15B
$1.99M 0.27%
24,000
– –
TREX icon
44
Trex
TREX
$4.51B
$1.92M 0.26%
113,404
+47,804
+73% +$807K
ESPR
45
DELISTED
Esperion Therapeutics
ESPR
$1.9M 0.25%
40,966
+13,566
+50% +$499K
TSS
46
DELISTED
Total System Services, Inc.
TSS
$1.86M 0.25%
+31,930
New +$1.83M
PTCT icon
47
PTC Therapeutics
PTCT
$5.64B
$1.79M 0.24%
+97,789
New +$1.32M
ENOV icon
48
Enovis
ENOV
$1.68B
$1.77M 0.24%
26,105
-246
-0.9% -$16.8K
HUM icon
49
Humana
HUM
$43.7B
$1.74M 0.23%
+7,212
New +$1.63M
PRTK
50
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1.73M 0.23%
+71,799
New +$1.59M
1
2
3 4 5

Similar funds

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
RRC
Range Rock Capital Wellesley, Massachusetts $46.7M AUM
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
NPCM
New Paradigm Capital Management Great Falls, Virginia $46.8M AUM
FCM
Firsthand Capital Management San Jose, California $46.9M AUM 114.33% 1-Year Est. Return
EGI
EAM Global Investors Solana Beach, California $47.1M AUM 320.45% 1-Year Est. Return
IPHI
Inflection Point Holdings II New York $47.3M AUM
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Crestline Management's Q2 2017 Portfolio in Review

As of Q2 2017, Crestline Management held 190 positions worth $746M, up 37% from $546M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Crestline Management deployed $60.8M of net new capital in Q2 2017, opening 78 new positions and adding to 30 existing holdings. Its largest new stake was Monsanto Co: 53,000 shares worth $6.27M.

By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 8% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was FNB Corp, an estimated $5.19M trimmed.

  • Crestline Management's largest Q2 2017 buy was Monsanto Co: 53,000 shares worth $6.27M.
  • Crestline Management added most to Honeywell in Q2 2017, an estimated $4.05M increase.
  • Crestline Management's biggest Q2 2017 reduction was FNB Corp, cutting an estimated $5.19M.
  • Crestline Management fully exited Dover in Q2 2017, selling an estimated $4.9M.
  • Crestline Management's ten largest holdings make up 77% of its $746M portfolio in Q2 2017.
  • Crestline Management opened 78 new positions and closed 61 in Q2 2017.
  • Crestline Management's portfolio value rose 37% quarter-over-quarter to $746M.

Based on Crestline Management's 13F filing for Q2 2017, filed 14 Aug 2017.